Company Directory / research
PrivateFor profitresearchBoston, United States
Kojin Therapeutics
Kojin is a biopharmaceutical company that develops new targeted therapeutics based on cell state and ferroptosis biology.
- Founded
- 2020 6 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $60M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
6 years old.
Reach
Website ranked #4,554,772 in the world for traffic, about 2k visits a month.
What it does
BiopharmaBiotechnologyHealth CareLife ScienceMedical
Funding, as listed
$60M currency not stated
- Rounds1
- LatestSeries a, Jun 2021
- Investors8, 3 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Kojin Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- Kojin Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2020
- Founders
- Benjamin Cravatt, Stephanie Dougan, Vasanthi Viswanathan
- Industry
- research
- Categories
- Biopharma, Biotechnology, Health Care, Life Science, Medical
Where
- City
- Boston
- Country
- United States
- Markets
- Greater Boston Area, East Coast, New England, Northeastern US
Size and reach
- Staff band
- 11-50
- Web traffic rank
- #4,554,772
- Monthly web visits
- 2,098
Funding, as listed
- Total
- 60,000,000 (currency not stated)
- Rounds
- 1
- Latest round
- Series a
- Latest round date
- Jun 2021
- Investors
- 8
- Lead investors
- 3
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Companies like it
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.